Mary Anissa Sinnathamby
0000-0001-6212-4672
36 papers found
Refreshing results…
Descriptive epidemiology of SARS‐CoV‐2 Beta (B.1.351) variant cases in England, December 2020 to June 2022
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from Autumn 2020 to Summer 2022
Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A Streptococcus (GAS) Infection in England
An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection
Epidemiological impact of the paediatric live attenuated influenza vaccine (LAIV) programme on group AStreptococcus(GAS) infections in England
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups
Transmission dynamics of COVID-19 in household and community settings in the United Kingdom, January to March 2020
Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in England
Transmission of SARS-CoV-2 in the household setting: A prospective cohort study in children and adults in England
Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: Prospective, national observational cohort surveillance, July-December 2020, England
The impact of social and physical distancing measures on COVID-19 activity in England: findings from a multi-tiered surveillance system
Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020
COVID-19 Outbreaks in Nurseries During Rapid Spread of the B.1.1.7 Variant of SARS-CoV-2 in England: Cross-Sectional National Surveillance, November 2020 – January 2021
Assessment of Mortality and Hospital Admissions Associated with Confirmed Infection with SARS-CoV-2 Variant of Concern VOC-202012/01 (B.1.1.7) a Matched Cohort and Time-to-Event Analysis
Six-year experience of detection and investigation of possible Middle East Respiratory Syndrome coronavirus cases, England, 2012–2018
Epidemiological and clinical characteristics of early COVID-19 cases, United Kingdom of Great Britain and Northern Ireland
Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-Cov-2 status in England
Missing publications? Search for publications with a matching author name.